Distinguishing between various types of blood stem cells (HSCs)—the stem cells that give rise to various blood cells—and multipotent progenitors (MPPs) has long been a challenging but critical task. These cells are responsible for replenishing our blood supply, making their identification essential for both basic research and clinical applications such as bone marrow transplants
read moreThe Coriell Institute for Medical Research is proud to announce the expansion of the National Eye Institute’s Genetic Repositories with the addition of biospecimens from the Age-Related Eye Disease Study 2 (AREDS2), sponsored by the National Eye Institute (NEI).
read moreThe Allen Cell Collection, housed and distributed from the Coriell Institute for Medical Research, added this week its first collection of disease-specific induced pluripotent stem cells.
read moreNew induced pluripotent stem cell (iPSC) lines derived from patients with CDKL5 Deficiency Disorder (CDD) have been added to the Orphan Disease Center Collection in the CDKL5 BioRepository, housed at the Coriell Institute for Medical Research.
read moreThe William G. Rohrer Charitable Foundation has awarded the Coriell Institute for Medical Research $500,000 to develop the Coriell-Cooper Cancer Biobank, a new collection of biological samples derived from people undergoing treatment for cancer.
read moreThe Coriell Institute for Medical Research announces the promotion of Denise Buscher, a longtime member of the Coriell team, as its new Chief Financial Officer.
read moreScientists from the Camden Opioid Research Initiative analyzed the toxicology findings from dozens of people who died from opioid overdoses and their findings were published this week in PLOS ONE.
read moreNew induced pluripotent stem cell (iPSC) lines have been added to the National Human Genome Research Institute’s Sample Repository for Human Genetic Research (NHGRI Repository). These two iPSC lines are the first of their kind to be introduced to the collection.
read moreThe Coriell Institute for Medical Research is proud to announce the addition of two scientists to its research team: Shumei Song, MD, PhD, and Nora I. Engel, PhD. Dr. Song and Dr. Engel will each lead labs at Coriell and their work will contribute to and benefit from the newly formed Camden Cancer Research Center (or CCRC), a three-way partnership between Coriell, Cooper University Health Care, and Cooper Medical School of Rowan University to study cancer biology and develop new therapies.
read moreIn a significant collaborative effort, the Coriell Institute for Medical Research, Cooper University Health Care, and Cooper Medical School of Rowan University (CMSRU) have launched the Camden Cancer Research Center (CCRC), a partnership to investigate cancer and translate basic cancer science into new treatments. The three organizations have pledged an initial $30 million to start this center.
read more